# CRISPR Therapeutics AG > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/crispr-therapeutics-ag | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 26 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:52:00.216745+00:00 | | Last reviewed | 2026-10-16T13:52:00.216745+00:00 | ## Identity - Legal name: CRISPR Therapeutics AG - Display name: CRISPR Therapeutics AG ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T04:44:57.466665+00:00 | | Completeness | 0.409 | | Record Quality | 0.848 | | Directors | 11 | | Committees | 4 | | Governance events | 18 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Ali Behbahani, M.D.: Director. Status: current. Independent: true. Since: 2015-01-01. claim_id=alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:6 - Briggs W. Morrison, M.D.: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:7 - Christian Rommel, Ph.D.: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:8 - Douglas A. Treco, Ph.D.: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:9 - H. Edward Fleming, Jr., M.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:10 - John T. Greene: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit (chair); Audit · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:11 - Katherine A. High, M.D.: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:12 - Maria Fardis, Ph.D.: Director. Status: current. Independent: true. Since: 2022-01-01. claim_id=alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:13 - Samarth Kulkarni, Ph.D.: Director. Status: current. Independent: false. Since: 2018-01-01. claim_id=alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:14 - Sandesh Mahatme, LL.M.: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:15 - Simeon J. George, M.D.: Director. Status: current. Independent: true. Since: 2015-01-01. claim_id=alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:16 ## Committees - Audit (audit). Chair: John T. Greene. Members: John T. Greene (chair, current). committee_id=alpha:committee:crispr-therapeutics-ag:audit - Audit · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: John T. Greene (member, current). committee_id=alpha:committee:crispr-therapeutics-ag:audit-chair-compensation - Compensation (compensation). Chair: NOT_PUBLISHED. Members: John T. Greene (member, current). committee_id=alpha:committee:crispr-therapeutics-ag:compensation - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Katherine A. High, M.D. (member, current). committee_id=alpha:committee:crispr-therapeutics-ag:nominating-and-governance ## Executive leadership - James R. Kasinger: General Counsel and Secretary [GC]. Status: current. claim_id=alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:17 - Naimish Patel, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:18 - Raju Prasad, Ph.D.: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:19 - Samarth Kulkarni, Ph.D.: Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:20 ## Governance events - GC_CHANGED: James R. Kasinger executive of CRISPR Therapeutics AG, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:n0uudgvym1gq - EXECUTIVE_APPOINTED: Naimish Patel, M.D. executive of CRISPR Therapeutics AG, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:pq75n01ith13w - CFO_CHANGED: Raju Prasad, Ph.D. executive of CRISPR Therapeutics AG, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:68o8fo165cv4k - CEO_CHANGED: Samarth Kulkarni, Ph.D. executive of CRISPR Therapeutics AG, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:88ac12joutba - DIRECTOR_APPOINTED: Briggs W. Morrison, M.D. seat on CRISPR Therapeutics AG, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:1gxqt3p1pywqjv - DIRECTOR_APPOINTED: Christian Rommel, Ph.D. seat on CRISPR Therapeutics AG, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:1mlt78dc1mhgp - DIRECTOR_APPOINTED: Sandesh Mahatme, LL.M. seat on CRISPR Therapeutics AG, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:32q10l1mjtixh - DIRECTOR_APPOINTED: Maria Fardis, Ph.D. seat on CRISPR Therapeutics AG, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:102p98v19b133t - DIRECTOR_APPOINTED: H. Edward Fleming, Jr., M.D. seat on CRISPR Therapeutics AG, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:cuy8i914kq7np - DIRECTOR_APPOINTED: Douglas A. Treco, Ph.D. seat on CRISPR Therapeutics AG, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:1qw4gk81vygei4 - DIRECTOR_APPOINTED: John T. Greene seat on CRISPR Therapeutics AG, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:1950itxs9dqyj - DIRECTOR_APPOINTED: Katherine A. High, M.D. seat on CRISPR Therapeutics AG, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:1fc3s2aq8n9g8 - COMMITTEE_CREATED: Audit · Chair; Compensation committee of CRISPR Therapeutics AG, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:1i5y6q717fsanj - COMMITTEE_MEMBER_ADDED: John T. Greene member of Audit · Chair; Compensation, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:ba6vgb14hyo9 - COMMITTEE_MEMBER_ADDED: Katherine A. High, M.D. member of Nominating and Governance, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:apuqnz98x29x - DIRECTOR_APPOINTED: Samarth Kulkarni, Ph.D. seat on CRISPR Therapeutics AG, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:3nqvdfrqtqbv - DIRECTOR_APPOINTED: Ali Behbahani, M.D. seat on CRISPR Therapeutics AG, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:nadcbnaldond - DIRECTOR_APPOINTED: Simeon J. George, M.D. seat on CRISPR Therapeutics AG, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:llg1iw4e2m2k ## Scoped resources - `alpha://company/crispr-therapeutics-ag` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record - `alpha://company/crispr-therapeutics-ag/identity` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=identity - `alpha://company/crispr-therapeutics-ag/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=corporate-structure - `alpha://company/crispr-therapeutics-ag/board` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=board - `alpha://company/crispr-therapeutics-ag/committees` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=committees - `alpha://company/crispr-therapeutics-ag/leadership` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=leadership - `alpha://company/crispr-therapeutics-ag/ownership` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=ownership - `alpha://company/crispr-therapeutics-ag/financials` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=financials - `alpha://company/crispr-therapeutics-ag/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=capital-structure - `alpha://company/crispr-therapeutics-ag/compensation` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=compensation - `alpha://company/crispr-therapeutics-ag/governance` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=governance - `alpha://company/crispr-therapeutics-ag/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=shareholder-governance - `alpha://company/crispr-therapeutics-ag/audit` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=audit - `alpha://company/crispr-therapeutics-ag/legal` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=legal - `alpha://company/crispr-therapeutics-ag/risk` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=risk - `alpha://company/crispr-therapeutics-ag/cyber` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=cyber - `alpha://company/crispr-therapeutics-ag/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=ai-governance - `alpha://company/crispr-therapeutics-ag/agents` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=agents - `alpha://company/crispr-therapeutics-ag/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=ecosystem - `alpha://company/crispr-therapeutics-ag/events` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=events - `alpha://company/crispr-therapeutics-ag/relationships` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=relationships - `alpha://company/crispr-therapeutics-ag/assessments` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=assessments - `alpha://company/crispr-therapeutics-ag/evidence` (contract): https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:john-t-greene","name":"John T. Greene"},"source_id":"board_seats"}` - Claim alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:john-t-greene","name":"John T. Greene"},"source_id":"board_seats"}` - Claim alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:katherine-a-high-md","name":"Katherine A. High, M.D."},"source_id":"board_seats"}` ## Leadership - Ali Behbahani, M.D.: Director. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:6. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98. - Briggs W. Morrison, M.D.: Director. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:7. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98. - Christian Rommel, Ph.D.: Director. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:8. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98. - Douglas A. Treco, Ph.D.: Director. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:9. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98. - H. Edward Fleming, Jr., M.D.: Director. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:10. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98. - John T. Greene: Director, Audit · Chair; Compensation. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:11. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98. - Katherine A. High, M.D.: Director, Nominating and Governance. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:12. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98. - Maria Fardis, Ph.D.: Director. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:13. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98. - Samarth Kulkarni, Ph.D.: Director. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:14. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98. - Sandesh Mahatme, LL.M.: Director. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:15. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98. - Simeon J. George, M.D.: Director. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:16. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98. - James R. Kasinger: General Counsel and Secretary. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:17. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e9a5c69acc146fbb30c88226413138788ec6364a0fca7d85e4f6197e79f4f3ea. - Naimish Patel, M.D.: Chief Medical Officer. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:18. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b88b7de8b1932f76df41e30ba7cba0c64bd6211bdef2e63f26715c2619a18a99. - Raju Prasad, Ph.D.: Chief Financial Officer. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:19. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a8412d5bb50c0528d1ebe2dad4857eedcbae3a2b6b1c411515139731e2e460f1. - Samarth Kulkarni, Ph.D.: Chief Executive Officer. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:20. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a6f402a1d0006994498d4b437c6a7dbe03aa7dead593633b3e83a95a13a661a2. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair John T. Greene; Members John T. Greene (Chair). Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a408978f1d28b8720001c2ed21432288beba2d22d1f13ea16ea9b51dd1464e37. - Compensation: Chair not stated; Members John T. Greene. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:committee_record:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a408978f1d28b8720001c2ed21432288beba2d22d1f13ea16ea9b51dd1464e37. - Nominating and Governance: Chair not stated; Members Katherine A. High, M.D.. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:committee_record:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a408978f1d28b8720001c2ed21432288beba2d22d1f13ea16ea9b51dd1464e37. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - CRISPR Therapeutics AG. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7dd37a87ce9b75aa280c261782785046056b589d02062e874182dba277135635. ## Entity Status - Public listing published. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7dd37a87ce9b75aa280c261782785046056b589d02062e874182dba277135635. ## Published Fact - US. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7dd37a87ce9b75aa280c261782785046056b589d02062e874182dba277135635. - Healthcare. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7dd37a87ce9b75aa280c261782785046056b589d02062e874182dba277135635. ## Committee Appointment - John T. Greene: chair, Audit. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a408978f1d28b8720001c2ed21432288beba2d22d1f13ea16ea9b51dd1464e37. - John T. Greene: member, Compensation. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a408978f1d28b8720001c2ed21432288beba2d22d1f13ea16ea9b51dd1464e37. - Katherine A. High, M.D.: member, Nominating and Governance. Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a408978f1d28b8720001c2ed21432288beba2d22d1f13ea16ea9b51dd1464e37. ## Security Listing - CRSP (NASDAQ). Claim: alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:security_listing:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7dd37a87ce9b75aa280c261782785046056b589d02062e874182dba277135635. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:7dd37a87ce9b75aa280c261782785046056b589d02062e874182dba277135635: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/crispr-therapeutics-ag). - alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98: [CRISPR Therapeutics DEF 14A 2026-04-21](https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm). - alpha:projection-evidence:document:e9a5c69acc146fbb30c88226413138788ec6364a0fca7d85e4f6197e79f4f3ea: [CRSP DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm). - alpha:projection-evidence:document:b88b7de8b1932f76df41e30ba7cba0c64bd6211bdef2e63f26715c2619a18a99: [CRSP DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm). - alpha:projection-evidence:document:a8412d5bb50c0528d1ebe2dad4857eedcbae3a2b6b1c411515139731e2e460f1: [CRSP DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm). - alpha:projection-evidence:document:a6f402a1d0006994498d4b437c6a7dbe03aa7dead593633b3e83a95a13a661a2: [CRSP DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm). - alpha:projection-evidence:a408978f1d28b8720001c2ed21432288beba2d22d1f13ea16ea9b51dd1464e37: [Audit](https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/crispr-therapeutics-ag) - [Public Markdown](https://registry.alpha.ac/companies/crispr-therapeutics-ag.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=jsonld) - MCP resource: `alpha://companies/crispr-therapeutics-ag` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T04:44:57.277494+00:00; recorded 2026-10-17T04:44:57.277494+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.